Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Apr 8;8(6):933-937.
doi: 10.1002/ccr3.2706. eCollection 2020 Jun.

Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report

Miriam Marangon  1 , Beatrice Casadei  1 , Alessandro Broccoli  1 , Lisa Argnani  1 , Michele Cavo  1 , Pier Luigi Zinzani  1
Affiliations
Case Reports

Management of central nervous system relapse in a young patient affected by primary mediastinal large B-cell lymphoma: A case report

Miriam Marangon et al. Clin Case Rep. .

Abstract

In primary mediastinal large B-cell lymphoma, central nervous system (CNS) relapse is an uncommon event with a dismal prognosis. We report about the successful management of CNS relapse with chemoimmunotherapy according to MATRix (methotrexate, cytarabine, thiotepa, and rituximab) protocol followed by autologous stem cell transplant.

Keywords: MATRix regimen; autologous stem cell transplant; central nervous system involvement; primary mediastinal large B‐cell lymphoma.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Figure 1
Figure 1
Magnetic resonance imaging at central nervous system lymphoma recurrence
Figure 2
Figure 2
Magnetic resonance imaging at the end of MATRix (methotrexate, cytarabine, thiotepa, and rituximab) regimen (complete response)
See this image and copyright information in PMC

References

    1. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375‐2390. - PMC - PubMed
    1. Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PWM. Primary mediastinal large B‐cell lymphoma. Crit Rev Oncol Hematol. 2017;113:318‐327. - PubMed
    1. Zinzani PL, Piccaluga PP. Primary Mediastinal DLBCL: evolving biologic understanding and therapeutic strategies. Curr Oncol Rep. 2011;13(5):407‐415. - PubMed
    1. Bishop PC, Wilson WH, Pearson D, Janik J, Jaffe ES, Elwood PC. CNS involvement in primary mediastinal large B‐cell lymphoma. J Clin Oncol. 1999;17(8):2479‐2485. - PubMed
    1. Papageorgiou SG, Diamantopoulos P, Levidou G, et al. Isolated central nervous system relapses in primary mediastinal large B‐cell lymphoma after CHOP‐like chemotherapy with or without Rituximab. Hematol Oncol. 2013;31(1):10‐17. - PubMed

Publication types

LinkOut - more resources